A recent study suggests that patients with high-risk prostate cancer (PCa) in need of renal transplantation should receive cancer treatment before their transplants, as surgery and radiation treatment ...

Nearly one quarter of men with stage IV prostate cancer (PCa) receive no treatment for the malignancy, data show. Eberechukwu Onukwugha, PhD, of the University of Maryland School of Pharmacy in ...

Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment ...

Several novel therapies for castration-resistant prostate cancer (CRPC) have been approved with randomized phase III studies with continuing observational research either planned or ongoing.

The COVID-19 pandemic has led to changes in prostate cancer care and research across the United States, but to varying degrees. Routine and nonessential healthcare services came to a nearly complete ...

“[…] manipulating LD dynamics represents a promising strategy to overcome hypoxia-induced resistance to ferroptosis and improve the success of PCa treatment ...